RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P40
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -2.48% |
| Q2 2025 | 2.47% |
| Q1 2025 | -74.08% |
| Q4 2024 | 248.25% |
| Q3 2024 | -41.08% |
| Q2 2024 | -8.64% |
| Q1 2024 | -7.41% |
| Q4 2023 | -0.95% |
| Q3 2023 | 24.86% |
| Q2 2023 | -15.37% |
| Q1 2023 | 31.46% |
| Q4 2022 | 17.20% |
| Q3 2022 | 15.60% |
| Q2 2022 | -13.86% |
| Q1 2022 | 16.58% |
| Q4 2021 | -9.07% |
| Q3 2021 | 19.22% |
| Q2 2021 | -4.22% |
| Q1 2021 | 26.29% |
| Q4 2020 | -15.55% |
| Q3 2020 | 17.53% |
| Q2 2020 | 2.84% |
| Q1 2020 | 4.84% |
| Q4 2019 | 18.74% |
| Q3 2019 | 3.81% |
| Q2 2019 | 5.04% |
| Q1 2019 | -6.09% |
| Q4 2018 | -8.72% |
| Q3 2018 | 33.06% |
| Q2 2018 | -5.56% |
| Q1 2018 | 0.00% |